Monopar Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Monopar Therapeutics Inc. (MNPR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 1.30 million shares as of 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2022-08-11
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.30M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.26M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.20M shares.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.14M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2022-06-30 | 1.30M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 1.26M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 1.20M shares 10-K · filed 2022-03-24 |
| 2021-09-30 | 1.14M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 1.09M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 1.04M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 989.90K shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 931.61K shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 872.93K shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 805.30K shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 758.58K shares 10-K · filed 2020-03-27 |
| 2019-09-30 | 690.28K shares 10-Q · filed 2019-11-12 |
| 2019-03-31 | 516.44K shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 465.19K shares 10-K · filed 2019-02-26 |
| 2018-09-30 | 437.21K shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 415.07K shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 381.97K shares 10-Q · filed 2018-05-11 |
| 2017-12-31 | 337.40K shares 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |